BDBM502331 N-{4-[7-(1H- benzo- imidazole-2- yl)-1-methyl- [1,2,4]tri- azolo[4,3- a]quinoxaline- 4-ylamino]- butyl}-2-(R)- hydroxy-3- methyl- butyramide::US11028090, Example 226

SMILES Cc1nnc2c(NCCCCNC(=O)[C@H](O)C(C)C)nc3cc(-c4nc5ccccc5[nH]4)ccc3n12

InChI Key InChIKey=PIGISGUETYOAQM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 502331   

TargetBromodomain-containing protein 4(Human)
Dong Wha Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 502331BDBM502331(N-{4-[7-(1H- benzo- imidazole-2- yl)-1-methyl- [1,...)
Affinity DataIC50: 4nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2021
Entry Details
US Patent